These data are in line with previous studies of Eμ-myc mice that found lymphoma latency to be influenced by IL-6 signaling [68] and that late onset lymphomas are distinct from early onset tumors reflecting distinctions between Burkitt’s lymphoma and DLBCL [41]. This evidence concerns the gene IL6 and lymphoma.